Royal Bank of Canada’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-82
| Closed | -$1K | – | 6654 |
|
|
2025
Q1 | $1K | Sell |
82
-227
| -73% | -$2.77K | ﹤0.01% | 6256 |
|
|
2024
Q4 | $4K | Buy |
309
+244
| +375% | +$3.16K | ﹤0.01% | 6074 |
|
|
2024
Q3 | $1K | Sell |
65
-20,045
| -100% | -$308K | ﹤0.01% | 6220 |
|
|
2024
Q2 | $272K | Buy |
20,110
+9,722
| +94% | +$131K | ﹤0.01% | 4138 |
|
|
2024
Q1 | $173K | Sell |
10,388
-973
| -9% | -$16.2K | ﹤0.01% | 4381 |
|
|
2023
Q4 | $153K | Buy |
11,361
+6,236
| +122% | +$84K | ﹤0.01% | 4789 |
|
|
2023
Q3 | $56K | Sell |
5,125
-26,693
| -84% | -$292K | ﹤0.01% | 5230 |
|
|
2023
Q2 | $411K | Buy |
31,818
+13,403
| +73% | +$173K | ﹤0.01% | 3702 |
|
|
2023
Q1 | $221K | Sell |
18,415
-3,194
| -15% | -$38.3K | ﹤0.01% | 4170 |
|
|
2022
Q4 | $297K | Buy |
21,609
+7,773
| +56% | +$107K | ﹤0.01% | 4093 |
|
|
2022
Q3 | $203K | Buy |
13,836
+7,658
| +124% | +$112K | ﹤0.01% | 4287 |
|
|
2022
Q2 | $94K | Buy |
6,178
+528
| +9% | +$8.03K | ﹤0.01% | 4911 |
|
|
2022
Q1 | $102K | Sell |
5,650
-16,857
| -75% | -$304K | ﹤0.01% | 5156 |
|
|
2021
Q4 | $536K | Sell |
22,507
-23,474
| -51% | -$559K | ﹤0.01% | 3892 |
|
|
2021
Q3 | $1.42M | Buy |
45,981
+7,148
| +18% | +$221K | ﹤0.01% | 2950 |
|
|
2021
Q2 | $1.24M | Buy |
38,833
+15,684
| +68% | +$500K | ﹤0.01% | 3102 |
|
|
2021
Q1 | $693K | Buy |
23,149
+4,015
| +21% | +$120K | ﹤0.01% | 3473 |
|
|
2020
Q4 | $607K | Sell |
19,134
-139
| -0.7% | -$4.41K | ﹤0.01% | 3482 |
|
|
2020
Q3 | $529K | Sell |
19,273
-3,661
| -16% | -$100K | ﹤0.01% | 3363 |
|
|
2020
Q2 | $621K | Sell |
22,934
-3,129
| -12% | -$84.7K | ﹤0.01% | 3181 |
|
|
2020
Q1 | $510K | Sell |
26,063
-5,710
| -18% | -$112K | ﹤0.01% | 3169 |
|
|
2019
Q4 | $745K | Buy |
31,773
+721
| +2% | +$16.9K | ﹤0.01% | 3154 |
|
|
2019
Q3 | $583K | Buy |
31,052
+5,547
| +22% | +$104K | ﹤0.01% | 3214 |
|
|
2019
Q2 | $539K | Buy |
25,505
+17,238
| +209% | +$364K | ﹤0.01% | 3293 |
|
|
2019
Q1 | $174K | Sell |
8,267
-2,173
| -21% | -$45.7K | ﹤0.01% | 3881 |
|
|
2018
Q4 | $197K | Sell |
10,440
-18,384
| -64% | -$347K | ﹤0.01% | 3753 |
|
|
2018
Q3 | $716K | Buy |
28,824
+3,427
| +13% | +$85.1K | ﹤0.01% | 3096 |
|
|
2018
Q2 | $613K | Buy |
25,397
+3,961
| +18% | +$95.6K | ﹤0.01% | 3104 |
|
|
2018
Q1 | $623K | Buy |
21,436
+9,651
| +82% | +$280K | ﹤0.01% | 2991 |
|
|
2017
Q4 | $280K | Sell |
11,785
-1,530
| -11% | -$36.4K | ﹤0.01% | 3525 |
|
|
2017
Q3 | $360K | Sell |
13,315
-10,100
| -43% | -$273K | ﹤0.01% | 3404 |
|
|
2017
Q2 | $540K | Sell |
23,415
-1,550
| -6% | -$35.7K | ﹤0.01% | 2997 |
|
|
2017
Q1 | $606K | Buy |
24,965
+10,632
| +74% | +$258K | ﹤0.01% | 2927 |
|
|
2016
Q4 | $305K | Buy |
14,333
+661
| +5% | +$14.1K | ﹤0.01% | 3487 |
|
|
2016
Q3 | $353K | Buy |
13,672
+2,790
| +26% | +$72K | ﹤0.01% | 3316 |
|
|
2016
Q2 | $247K | Buy |
10,882
+3,375
| +45% | +$76.6K | ﹤0.01% | 3594 |
|
|
2016
Q1 | $163K | Buy |
7,507
+7,257
| +2,903% | +$158K | ﹤0.01% | 3847 |
|
|
2015
Q4 | $7K | Buy |
+250
| New | +$7K | ﹤0.01% | 5295 |
|